The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Nozomi Niitsu

First Department of Internal Medicine

Toho University School of Medicine

Tokyo; Research Institute

Saitama Cancer Center

Saitama

[email]@med.kitasato-u.ac.jp

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • First Department of Internal Medicine, Toho University School of Medicine, Tokyo; Research Institute, Saitama Cancer Center, Saitama. 2001 - 2005
  • First Department of Internal Medicine, Toho University School of Medicine, Japan. 2001 - 2004
  • Department of Hematology and Internal Medicine IV, School of Medicine, Kitasato University, Japan. 2001 - 2002

References

  1. Phase I/II study of the rituximab-EPOCT regimen in combination with granulocyte colony-stimulating factor in patients with relapsed or refractory follicular lymphoma including evaluation of its cardiotoxicity using B-type natriuretic peptide and troponin T levels. Niitsu, N., Khori, M., Hayama, M., Kajiwara, K., Higashihara, M., Tamaru, J. Clin. Cancer Res. (2005) [Pubmed]
  2. Phase I study of Rituximab-CHOP regimen in combination with granulocyte colony-stimulating factor in patients with follicular lymphoma. Niitsu, N., Hayama, M., Okamoto, M., Khori, M., Higashihara, M., Tamaru, J., Hirano, M. Clin. Cancer Res. (2004) [Pubmed]
  3. Primary gastric T-cell lymphoma not associated with human T-lymphotropic virus type I: a case report and review of the literature. Niitsu, N., Nakamine, H., Kohri, M., Hayama, M., Tamaru, J., Iwabuchi, K., Tanabe, S., Horie, R., Higashihara, M. Ann. Hematol. (2003) [Pubmed]
  4. Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma. Niitsu, N., Nakamine, H., Okamoto, M., Akamatsu, H., Honma, Y., Higashihara, M., Okabe-Kado, J., Hirano, M. Br. J. Haematol. (2003) [Pubmed]
  5. High serum soluble CD44 is correlated with a poor outcome of aggressive non-Hodgkin's lymphoma. Niitsu, N., Iijima, K. Leuk. Res. (2002) [Pubmed]
  6. Simultaneous elevation of the serum concentrations of vascular endothelial growth factor and interleukin-6 as independent predictors of prognosis in aggressive non-Hodgkin's lymphoma. Niitsu, N., Okamato, M., Nakamine, H., Yoshino, T., Tamaru, J., Nakamura, S., Higashihara, M., Hirano, M. Eur. J. Haematol. (2002) [Pubmed]
  7. Human B-cell lymphoma cell lines are highly sensitive to apoptosis induced by all-trans retinoic acid and interferon-gamma. Niitsu, N., Higashihara, M., Honma, Y. Leuk. Res. (2002) [Pubmed]
  8. The catalytic DNA topoisomerase II inhibitor ICRF-193 and all-trans retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cells: candidate drugs for chemo-differentiation therapy against acute promyelocytic leukemia. Niitsu, N., Higashihara, M., Honma, Y. Exp. Hematol. (2002) [Pubmed]
  9. Ovarian follicular lymphoma: a case report and review of the literature. Niitsu, N., Nakamine, H., Hayama, M., Unno, Y., Nakamura, S., Horie, R., Iwabuchi, K., Nakamura, N., Miura, I., Higashihara, M. Ann. Hematol. (2002) [Pubmed]
  10. Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma. Niitsu, N., Okabe-Kado, J., Okamoto, M., Takagi, T., Yoshida, T., Aoki, S., Hirano, M., Honma, Y. Blood (2001) [Pubmed]
  11. Combination therapy with irinotecan (CPT-11), mitoxantrone, and dexamethasone in relapsed or refractory non-Hodgkin's lymphoma: a pilot study. Niitsu, N., Iijima, K., Chizuka, A. Ann. Hematol. (2001) [Pubmed]
  12. Full-dose CHOP chemotherapy combined with granulocyte colony-stimulating factor for aggressive non-Hodgkin's lymphoma in elderly patients: a prospective study. Niitsu, N., Iijima, K. Ann. Hematol. (2001) [Pubmed]
 
WikiGenes - Universities